First To Know

We're really looking forward to seeing you soon at the 11th Annual SYNChronicity Conference at the Renaissance Arlington Capital View Hotel, in Washington, DC! Organized by HealthHIV, HealthHCV, and the National Coalition for LGBTQ Health, this one-of-a-kind national conference brings together dynamic healthcare and public health audiences in harmony to effectively address HIV, hepatitis C(HCV), sexually transmitted infections (STIs), LGBTQ+ health, harm reduction, and health equity. We'll be set up at Table 21, ready to discuss how we can work towards a better future by addressing a number of ways we can address health equity and disease prevention together. Learn more about the conference and register here: bit.ly/477Cg5A We can't wait to see you there! #NOWDx #FirstToKnow #SYNC2026 #PublicHealth #HealthHIV #HealthLGBTQ

We're proud to announce that NOWDiagnostics will be attending the 2026 AMCHP Conference, taking place from March 7-10 in The Westin Washington, DC Downtown Hotel! The AMCHP Annual Conference is one of the largest gatherings of maternal and child health (MCH) professionals in the United States. Every year, the conference aims to highlight MCH programs’ impact at all levels on women, children, and families and to provide participants with tools and resources to develop, enhance, and sustain vital MCH programs and services. We'll be looking forward to meeting you at Booth 303. Let's chat and work together towards a healthier future for families and children. Learn more about the conference and what to expect: bit.ly/40dTfzd We can't wait to see you there! #NOWDx #FirstToKnow #AMCHP2026 #PublicHealth #ReproductiveHealth #PowerOfConnection

We're excited to announce that NOWDiagnostics will be attending the 2026 National Family Planning & Reproductive Health Association Conference, taking place from March 1-4 in Washington, DC! Stop by to discuss safety and cutting-edge technology in reproductive health and family planning. We'll be happy to see you at Exhibit 11. Let's connect and work together towards a healthier future. Learn more about the conference and what to expect: bit.ly/4kYarlD We can't wait to see you there! #NOWDx #FirstToKnow #NFPRHA2026 #PublicHealth #ReproductiveHealth

Take control of your health today. The First To Know® Syphilis Test gives you rapid, reliable results from the privacy of your own home in only 15 minutes. That's only 1 quarter of the Big Game. No waiting rooms. No appointments. Just answers when you need them. Learn more about the test at bit.ly/3Zkf9QR. #FirstToKnow #NOWDx #SyphilisAwareness #TakeControl #HealthAtHome #SexualHealth #BigGame

🎉 Please join us in congratulating Gabriella Miller, our 2025 Q4 Employee of the Quarter! Gabriella consistently goes above and beyond in her role, demonstrating an unwavering commitment to excellence each and every day. She has seamlessly taken on the responsibilities of multiple team members, handling major transitions with grace and determination, including bringing the customer support line in-house, managing customer calls, and ensuring products are mailed out accurately and on time. No matter the challenge, Gabriella maintains a positive attitude and a solutions-focused mindset, always working to ensure everything gets done when it needs to. Most notably, her continued dedication to NOWDx in the face of the catastrophic loss of her home is a powerful testament to her resilience, professionalism, and deep commitment to the team. Gabriella truly embodies what it means to be an Employee of the Quarter. #EmployeeRecognition #TeamNOWDx #EmployeeOfTheQuarter #AccountManagementExcellence #ThankYouGabriella

We will be closed on Monday, January 19th, in honor of Dr. Martin Luther King Jr. Day. #MartinLutherKingJrDay #NOWDx #FirstToKnow #NOWDiagnostics #PublicHealth

Happy New Year! We are so grateful for all that we were able to accomplish in 2025, and are excited for an even bigger 2026. #NewYear #2026 #Holidays #NOWDx #FirstToKnow #NOWDiagnostics #PublicHealth

NOWDx sincerely wishes you a very merry and meaningful Christmas holiday. #Christmas #Holidays #NOWDx #NOWDiagnostics #FirstToKnow #PublicHealth

#NOWDiagnostics Syphilis rates are still at epidemic levels in the US – it's more important than ever for sexually active individuals to test to determine their syphilis status. Take control of your health or help someone you care about with the First To Know® Syphilis Test—a new in-home blood test that delivers accurate results in just 15 minutes. It’s the perfect gift for privacy, confidence, and peace of mind this season. 👉 To learn more and order your test today visit bit.ly/4pMtDVc #FirstToKnow #NOWDx #Syphilis #Test #PublicHealth #STI #Prevention

Hello everyone, We’re pleased to announce that Dr. Hazim Aljewari has been promoted to Director of R&D, Molecular Biology. Since joining NOWDiagnostics®, Hazim has made immediate and meaningful contributions to our lab operations and molecular diagnostics program. Before NOWDx, Hazim spent several years at the University of Arkansas, where his work focused on molecular biology, biotechnology, genetics, and bioprocessing engineering. His strong translational research background allowed him to transition quickly into NOWDx and take on an early leadership role in molecular assay development. Hazim brings over a decade of research experience, with three patents and more than 50 peer-reviewed publications. He also has a broad international background, including research at Khon Kaen University in Thailand and an academic career in Iraq as an Assistant Professor at the University of Baghdad, where he also founded an international lab supply company. At NOWDx, Hazim has already played a key role in advancing proprietary molecular assays and solving polymerase inactivity in saliva—work now being captured as a provisional patent. His team’s dedication was clear when they worked through the Thanksgiving weekend to resolve critical reagent issues. The molecular program is central to NOWDx’s value, and Hazim’s leadership continues to strengthen it. He is a natural teacher and collaborator who brings great energy to the team. In his new role, Hazim will lead the day-to-day activities of the molecular group and report directly to Dr. Jody Berry, Chief Scientific Officer. Please join us in congratulating Dr. Hazim Aljewari on his well-deserved promotion. #NOWDiagnostics #NOWDx #FirstToKnow #PublicHealth #Prevention #MolecularBiology #Congratulations

Hello everyone, We’re pleased to announce that Dr. Hazim Aljewari has been promoted to Director of R&D, Molecular Biology. Since joining NOWDiagnostics®, Hazim has made immediate and meaningful contributions to our lab operations and molecular diagnostics program. Before NOWDx, Hazim spent several years at the University of Arkansas, where his work focused on molecular biology, biotechnology, genetics, and bioprocessing engineering. His strong translational research background allowed him to transition quickly into NOWDx and take on an early leadership role in molecular assay development. Hazim brings over a decade of research experience, with three patents and more than 50 peer-reviewed publications. He also has a broad international background, including research at Khon Kaen University in Thailand and an academic career in Iraq as an Assistant Professor at the University of Baghdad, where he also founded an international lab supply company. At NOWDx, Hazim has already played a key role in advancing proprietary molecular assays and solving polymerase inactivity in saliva—work now being captured as a provisional patent. His team’s dedication was clear when they worked through the Thanksgiving weekend to resolve critical reagent issues. The molecular program is central to NOWDx’s value, and Hazim’s leadership continues to strengthen it. He is a natural teacher and collaborator who brings great energy to the team. In his new role, Hazim will lead the day-to-day activities of the molecular group and report directly to Dr. Jody Berry, Chief Scientific Officer. Please join us in congratulating Dr. Hazim Aljewari on his well-deserved promotion. #NOWDiagnostics #NOWDx #FirstToKnow #PublicHealth #Prevention #MolecularBiology #Congratulations

NOWDiagnostics (NOWDx) Welcomes Nate Fecik as Our Newest Public Health Account Executive We are pleased to announce that Nathan “Nate” Fecik has joined NOWDiagnostics as our newest Public Health Account Executive. Nate comes to NOWDx with extensive experience in federal public health service. Most recently, he served as a Senior Public Health Advisor for Syndemics and Co-Principal for the Sexually Transmitted Infections portfolio within the Office of Infectious Disease and HIV/AIDS Policy (OIDP), Office of the Assistant Secretary for Health (OASH), U.S. Department of Health and Human Services (HHS) in Washington, D.C. In this role, Nate led the development of a new syndemics policy and strategic planning portfolio aimed at centering communities and addressing shared determinants of HIV, STIs, viral hepatitis, substance use, and mental health disorders. His work included facilitating a cross-agency, multidisciplinary working group to advance this integrated approach. Nate will assume responsibilities for promoting the First To Know® Syphilis Tests in all Public Health markets throughout the United States. Please join us in welcoming Nate to his new role at NOWDiagnostics. #NOWDiagnostics #NOWDx #FirstToKnow #PublicHealth

Syphilis is sometimes called the “great imitator” because its symptoms can look like many other conditions — or may not show up at all. That’s why regular testing is so important to protect our communities. With the First To Know® Syphilis Test, individuals can take control of their health right at home, and get reliable results in only 15 minutes. Learn more: bit.ly/3We2kG5 #NOWDx #FirstToKnow #Syphilis #InHomeTesting #PublicHealth #STI #Prevention #SexualHealth #SyphilisAwareness

Syphilis rates in the US remain high, but testing for syphilis has never been easier. With the First To Know® Syphilis Test, it's as simple as Touch. Tap. Test. It delivers accurate in-home results in just 15 minutes and is available over-the-counter at major retailers and Amazon. Learn more at bit.ly/3JaFuwp. #FirstToKnow #NOWDx #Syphilis #InHomeTesting #STI #Prevention #SexualHealth

According to the CDC, syphilis remains a serious public health issue. In 2023, the U.S. saw 209,253 total syphilis cases. While primary & secondary syphilis dropped ~10% from 2022 to 2023, late-stage cases rose ~12.8%. Why this matters: untreated syphilis can lead to severe health problems even years later. Learn how testing can catch syphilis early: bit.ly/46RKspI. Learn more about congenital syphilis: bit.ly/3IBdPEA #FirstToKnow #NOWDx #STIawareness #GetTested

According to the JAMA Network, Nearly 90% of congenital syphilis cases could have been prevented with proper prenatal care, timely testing, and treatment. Many pregnant women either don’t get prenatal care early enough, aren’t tested, or don’t receive treatment. You have power over prevention — ask for syphilis testing early in pregnancy. 👉 Learn more at bit.ly/487jcph. #FirstToKnow #NOWDx #PreventCongenitalSyphilis #MaternalHealth

Why wait for peace of mind? The First To Know® Syphilis Test makes it fast and easy to screen at home—with results in minutes. Protect yourself, protect your partners, and stay informed. Get yours today or learn more: bit.ly/4nrIUJT. #FirstToKnow #NOWDx #GetTested #InHomeTesting #STI #Prevention #SexualHealth

October 15 is National Latinx AIDS Awareness Day. HIV and syphilis are syndemic—meaning they often occur together and fuel each other’s spread. Protecting your health means staying informed, getting tested, and knowing your status. The First To Know® Syphilis Test is the first and only FDA-authorized in-home syphilis self-test, delivering accurate results in just 15 minutes. Learn more: bit.ly/4gNpw7M. Let’s stand together to promote testing, and support the Latinx community in achieving healthier futures. #FirstToKnow #NOWDx #NLAAD #HIVAIDS #SyphilisAwareness #GetTested

Penicillin remains the first-line treatment for all stages of syphilis and the only option in some cases. Delaying treatment can lead to serious long-term effects — but early diagnosis + timely treatment can prevent nearly all complications. 👉 If your First To Know® Syphilis Test is positive, don’t wait — visit bit.ly/4h9mHOE to connect with a healthcare provider. #FirstToKnow #NOWDx #TreatmentMatters #ActEarly #PublicHealth #GetTested #SexualHealth

Syphilis doesn’t affect everyone equally. In 2023: • Non-Hispanic Black/African American people experienced a disproportionate burden of STIs, including syphilis — making up about one-third of reported cases, while representing only about 13% of the U.S. population. • Rates of syphilis — including congenital syphilis passed from mother to baby — were among the highest in American Indian/Alaska Native communities, highlighting serious health disparities. Testing and treatment access matter—especially in communities with less access to healthcare. 👉Get informed — visit bit.ly/4gJCS4J. #FirstToKnow #NOWDx #SyphilisDisparities #PublicHealth #InHomeTesting #SexualHealth